Standout Papers
- The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP (2006)
- Introduction of Combined CHOP Plus Rituximab Therapy Dramatically Improved Outcome of Diffuse Large B-Cell Lymphoma in British Columbia (2005)
Immediate Impact
2 by Nobel laureates 12 from Science/Nature 66 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Works of Karamjit Gill being referenced
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma
2007
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Karamjit Gill | 2372 | 1539 | 842 | 19 | 2.9k | |
| Y Bastion | 2442 | 1612 | 1175 | 47 | 3.2k | |
| TP Miller | 1821 | 1982 | 689 | 28 | 3.2k | |
| Christine P. Hans | 3318 | 2033 | 1391 | 22 | 3.9k | |
| Catherine Sebban | 2265 | 1786 | 839 | 68 | 3.0k | |
| DD Weisenburger | 2050 | 1466 | 981 | 37 | 2.9k | |
| Andreas Lohri | 2019 | 1461 | 722 | 69 | 2.8k | |
| Achiel Van Hoof | 1893 | 1309 | 893 | 32 | 2.5k | |
| Pierre Feugier | 3126 | 2136 | 1317 | 79 | 3.7k | |
| Max Wolf | 1657 | 1036 | 768 | 55 | 2.0k | |
| F Swan | 2447 | 1690 | 1053 | 55 | 3.1k |
All Works
Loading papers...